传染病诊断市场基于(关键地区、市场参与者、规模和份额)- 到 2030 年的预测

  • Report Code : TIPHE100001430
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 280
Buy Now

【研究报告】传染病诊断市场预计将从2022年的383.6638亿美元增长到2030年的599.5422亿美元;预计 2022 年至 2030 年复合年增长率为 5.7%。
市场洞察和分析师观点:
随着传染病病例的增加以及产品推出和产品批准的增加,传染病诊断市场规模正在扩大。致力于开发技术先进的产品。 2022年5月,BD在美国推出全自动、高通量传染病分子诊断平台——BD COR MX仪器。该仪器自动化并集成了完整的分子实验室工作流程,从样品处理到大型高通量实验室的诊断测试结果。 BD COR 系统消除了对样本进行分类的任务,帮助实验室技术人员与样本进行最少的交互,从而为其他关键实验室流程腾出时间。为了应对不断增加的传染病病例以及实验室能力和分子检测试剂的短缺,一些诊断检测制造商提供快速且易于使用的设备来促进实验室外检测。
增长动力和挑战:
兽医传染病对家畜、牲畜和野生动物的健康产生负面影响。由于集约化畜牧业,每年在室内饲养的数十亿只动物(通常健康状况不佳)的遗传和身体接近性,为疾病流行的出现和扩大创造了条件。此外,由于农业用地扩大造成森林砍伐,畜牧业导致野生动物感染的传播。
能够在早期阶段检测新出现的传染性动物疾病的诊断技术对于减少与疾病爆发相关的经济损失至关重要此类疾病。聚合酶链式反应 (PCR) 仍然是全球检测动物病原体最广泛使用的分子检测方法。这种类型的诊断方法易于使用、经济有效、敏感且特异性强,能够进行大量检测。
尽管传统的病毒学方法非常可靠,但它们非常耗时且费力。程序。侧流层析和酶联免疫吸附测定可用于快速检测。多重微珠免疫或 Luminex 测定是一种基于荧光微珠的高通量定量技术,用于在一次反应中同时检测针对不同传染病的多种特异性抗体,与传统方法相比,可提供更快速、经济且准确的结果。常规ELISA。此外,基于表面等离子共振(SPR)的蛋白质芯片似乎是感染血清诊断或抗体滴定的快速有价值的工具。还可以使用 rDNA 技术在异源系统中生产重组抗体,并用于开发诊断测试。
即时诊断 (POCD) 是简单、快速、便携式的诊断设备,可以在现场检测疾病状态等级。近年来,实时PCR(qPCR)已转变为POCD平台。这些全自动平台结合了核酸提取、热循环和现场报告结果。例如,Enigma Diagnostics的MiniLab是一个10-35公斤的分子诊断平台,可在现场携带,用于验证非洲猪瘟病毒、猪瘟病毒、禽流感病毒和口蹄疫病毒用于研究目的。英国Primerdesign Ltd的genesig检测试剂盒提供冻干qPCR检测试剂盒,用于诊断62种牛、42种马、47种猪、60种禽、40种犬和26种猫病原体用于研究目的。同样,Boster 提供 Bosterbio qPCR 试剂盒,可检测多达 48 个单独或混合样本。它可用于基因表达谱分析、目标 DNA 定量、微生物检测、病毒或细菌病原体载量测定以及基于探针的 qPCR 的引物对性能评估。
因此,PCR 和 qPCR 等诊断方法可用于诊断细菌、病毒或细菌。动物中的病毒、真菌和寄生虫感染正在推动兽医诊断的发展。
大多数诊断测试的报销率较低,阻碍了制造公司开发新测试和进行大规模研究以支持广泛使用。此外,如果没有预期结果的数据来支持新测试的成本效益或证明现有测试,报销仍然很低。
对新的或昂贵的诊断测试报销的困难和担忧可能会阻碍创新并造成重大影响诊断技术广泛部署面临的挑战。在美国,报销包括第三方付款人的承保范围、确定付款的医疗服务或条件编码以及付款水平的确定。
对于使用当前程序术语 (CPT) 代码的门诊测试,医疗保险覆盖咨询委员会在诊断测试覆盖方面促进医疗保险和医疗补助服务中心 (CMS),包括确定足够的证据和健康福利。然而,大多数医疗保险报销决定都是在当地而不是在国家层面做出的。诊断测试的覆盖范围因地区而异。此外,缺乏确定覆盖范围的标准可能会给新诊断产品的开发和可用性带来挑战。
在某些情况下,报销不包括测试成本,这限制了实验室提供测试并降低了测试可用性和使用。在其他情况下,收费可能很高,但可能会给患者留下相当大的成本,这限制了医生定期进行检查。合规性和计费仍然是临床实验室面临的挑战,并限制了测试的可用性。因此,报销不足阻碍了传染病诊断市场的增长。
战略见解
报告细分和范围:
传染病诊断市场按产品细分为试剂盒和试剂、仪器、以及软件和服务。传染病诊断市场按技术分为基于生物传感器的诊断、免疫诊断、基于分子的诊断、临床生物学等。免疫诊断领域的市场进一步细分为酶联免疫吸附测定、蛋白质印迹分析和免疫荧光测定。基于分子的诊断技术领域的市场进一步细分为聚合酶链式反应、原位杂交、等温核酸扩增技术、下一代测序、DNA微阵列等。传染病诊断市场按应用类型分为即时检测和实验室检测。传染病诊断市场按测试类型分为人体测试和兽医测试。人体检测市场进一步细分为艾滋病毒、肝炎、HAIs、HPV、结核病、流感等。按最终用户划分,传染病诊断市场分为诊断实验室、医院和诊所、研究机构、家庭护理机构等。根据地理位置,传染病诊断市场分为北美(美国、加拿大和墨西哥)、欧洲(英国、德国、法国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本) 、印度、韩国、澳大利亚和亚太地区其他地区)、中东和非洲(阿联酋、沙特阿拉伯、南非以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷) ,以及南美洲和中美洲的其他地区)。
细分分析:
传染病诊断市场按产品细分为试剂盒和试剂、仪器以及软件和服务。 2022年,试剂盒和试剂细分市场占据最大市场份额。然而,软件和服务领域的市场预计将在 2022 年至 2030 年期间以最快的速度增长。由于雅培等大量制造商的存在,试剂盒和试剂领域正在增长; F.霍夫曼-拉罗氏有限公司;此外,为了应对 HAI、流感和 HIV 等传染病病例的不断增加以及基于实验室的分子检测能力和试剂的短缺,多家诊断检测制造商已经开发并开始销售快速和可靠的产品。易于使用的设备,以方便在实验室环境之外进行测试。此外,试剂盒和试剂在各种研究过程中频繁使用,并且产品推出量不断增加。例如,2021年7月,Cepheid宣布其Xpert HIV-1病毒载量XC和Xpert HIV-1 Qual XC(用于HIV检测的下一代扩展覆盖(XC)测试)已获得CE-IVD许可。 Xpert HIV-1 病毒载量 XC 为 HIV-1 检测提供了第二个目标,可扩展毒株覆盖范围,以提高性能并降低因基因突变或缺失而导致假阴性结果的风险。因此,由于提供多种试剂和试剂盒的各种市场参与者的存在以及技术进步的进步,预计该细分市场将在预测期内增长。
软件和服务细分市场预计将在未来几年,由于技术进步不断进步和采用新软件来减少传染病负担等因素。许多公司正在推出软件来分析传染病发病率的上升,预测一段时间内的趋势和爆发情况,并评估遏制措施的有效性。因此,建立了一些统计模型,主要基于易感者-暴露-感染-恢复或移除(SEIR)模型。此外,受到科学界多学科和协作努力的启发,疾病建模研究所一直在构建建模工具,这些工具是研究和软件团队成员之间广泛合作的成果。这些工具提供了定量和分析手段,用模型来表示传染病的传播。 IDM 软件工具与科学界自由、公开地共享,以借助计算模型加快疾病根除工作。因此,主要参与者采取的此类举措预计也将在未来几年推动该细分市场的增长。
按产品划分的传染病诊断市场 - 2022 年和 2030 年
区域分析:
根据地理位置,传染病诊断市场分为北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲。北美是全球传染病诊断市场增长的最大贡献者。预计 2022 年至 2030 年,亚太地区传染病诊断市场复合年增长率最高。美国传染病诊断市场的增长主要是由传染病患病率的增加、老年人口的增加以及主要参与者推出的产品数量的增加推动的。衰老是传染病的一个重要危险因素,因为 60 岁以上的人免疫力普遍下降。根据人口资料局2020年发布的研究报告,2020年美国65岁及以上人口为5500万,预计到2060年将达到9500万。美国监管机构正在实施优惠政策开发用于诊断和治疗各种适应症的即时护理 (POC) 产品的政策。 2021 年 3 月,美国食品药品监督管理局 (FDA) 授权 Binx Health IO CT/NG Assay 用于社区诊所、紧急护理机构和门诊医疗机构;它是第一个用于诊断衣原体和淋病感染的 POC 检测产品。 2022 年 5 月,全球领先的医疗技术公司之一 Becton Dickinson and Company (BD) 宣布在美国市场推出其新型全自动、高通量传染病分子诊断平台。新的 BD COR MX 仪器作为 BD COR 平台的分析仪器选项推出,并获得 FDA 510(k) 许可。 BD CTGCTV2 分子测定是新系统上可用的第一个测试,是一种单一测试,可检测三种最流行的非病毒性传播感染 (STI)——淋病奈瑟菌 (GC)、沙眼衣原体 (CT) 和阴道毛滴虫(电视)。
行业发展和未来机遇:
传染病诊断市场主要参与者的各种举措如下:
2023 年 1 月,Trinity Biotech 宣布与 imaware Inc 建立战略合作伙伴关系,将他们的内置-数字健康平台与 Trinity Biotech 先进的参考实验室设施合作,通过家庭和远程测试项目为数字健康行业提供动力。2022 年 11 月,Bio-Rad Laboratories Inc 扩大了其独立质量控制的产品组合,包括 InteliQ 和 Liquichek Compact小瓶。该产品将用于雅培的 Alinity CI 系列,该系列集成了临床化学和免疫分析检测仪器。2021 年 12 月,F. Hoffmann-La Roche Ltd 在新型分子实验室 cobas 5800 系统上推出了首次传染病检测仪器,在接受 CE 标志的国家。其中包括 cobas HIV-1、cobas HBV、cobas HCV、cobas HIV-1/HIV-2 定性和 cobas 全方位实用通道套件。这些产品的推出通过在低、中和高容量分子实验室测试需求中提供标准化的性能和效率,扩展了罗氏分子产品组合。竞争格局和主要公司:
Abbott Laboratories、Bruker Corp、Cardinal Health、F. Hoffmann- La Roche Ltd、Trinity Biotech Plc、Danaher Corp、Bio-Rad Laboratories Inc、AccuBioTech Co Ltd、ACON Laboratories 和 DiaSorin SpA 是传染病诊断市场的知名参与者。这些公司专注于新产品发布和地域扩张,以满足世界各地不断增长的消费者需求,并扩大其专业产品组合的产品范围。他们的全球业务使他们能够为大量客户提供服务,从而促进市场扩张。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What are the driving factors for the infectious disease diagnostics market across the country?

The factors that are driving and restraining factors that will affect the infectious disease diagnostics market in the coming years Growth of the global infectious disease diagnostic market is majorly driven by increase in prevalence of infectious disease such as hepatitis, influenza, COVID-19, & human immuno deficiency virus (HIV); rise in demand for point-of-care diagnostic test; increase in funding from private & government organizations for diagnostic service centers; and advancements in technologies in the field of infectious disease diagnostics. However, lack of reimbursement policy is likely to hinder the market growth.

Which segment is dominating the infectious disease diagnostics market?

The infectious disease diagnostics market, by disease indication, is bifurcated into human testing and veterinary testing. In 2022, the human segment held a larger share of the market, by testing type. However, the veterinary segment is expected to witness a higher growth during the forecast period.

Who are the major players in market the infectious disease diagnostics market?

The infectious disease diagnostics market majorly consists of the players such as F.Hoffmann-La Roche, Ltd.; Danaher Corporation; BD; bioMérieux SA; AccuBioTech Co., Ltd.; Bio-Rad Laboratories, Inc.; ACON Laboratories, Inc.; Abbott; Trinity Biotech; and Cardinal Health, Inc. amongst others.

What is the infectious disease diagnostics market?

Infectious diseases are generated by microorganisms such as fungi, viruses, bacteria, and other organism species. Infectious disease diagnostics are the methods utilized by hospitals, clinical laboratories, and others to detect or identify foreign antigens/organisms by using several diagnostic tests. These tests assist in the identification of the kind of pathogen. Also, the level of the degree to which the disease is spread in the body. The diagnostic procedure may be sent with the aid of conventional diagnostic tests or point-of-care testing tools.

The List of Companies - Infectious Disease Diagnostics Market 

  1. Abbott Laboratories
  2. Bruker Corp
  3. Cardinal Health
  4. F. Hoffmann-La Roche Ltd
  5. Trinity Biotech Plc
  6. Danaher Corp
  7. Bio-Rad Laboratories Inc
  8. AccuBioTech Co Ltd
  9. ACON Laboratories
  10. DiaSorin SpA

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports